Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.

Authors:
Address: MSD Animal Health, Wim de Korverstraat 35, PO Box 31, 5830 AA, Boxmeer, The Netherlands. mirjam.vandersluijs@merck.com
Journal:


Publication:

abstract

The Effect of vaccination with a commercial inactivated Bluetongue virus serotype 8 (BTV-8) vaccine on the ability of BTV-8 to cross the ruminant placenta was investigated in two experiments. Ten pregnant ewes (Experiment 1) or heifers (Experiment 2) were vaccinated according to the manufacturer's instructions. Three weeks after the completion of the vaccination schedule, all vaccinated animals were infected with BTV-8 together with ten non-vaccinated pregnant animals that served as challenged controls. Four additional pregnant animals received a mock challenge at the same time point. Three weeks after the challenge, the foetuses were collected. In the sheep experiment, the lambs of the vaccinated ewes and the mock infected ewes were negative in the virus isolation, whereas BTV-8 could be isolated from 11/23 lambs of 6/10 ewes in the BTV-8 challenged control group. The incidence and severity of BTV associated lesions, such as haemorrhages, meningitis/encephalitis and necrosis in the placentomes was significantly higher in the BTV-8 challenged control group. The rate of transplacental transmission was less in the cattle experiment: BTV-8 could be detected in 2/10 calves in the BTV-8 challenged control group. All other calves were negative. Vaccination clearly reduced transplacental transmission of BTV-8 in the sheep experiment, whereas in the cattle experiment, the incidence of transmission was too low to demonstrate a significant reduction of transmission by vaccination. However, the vaccine very effectively blocked viraemia, which suggests that the vaccine might prevent transmission in cattle as well. Transplacental transmission of BTV has serious economical consequences, due to the loss of progeny to the livestock industry. Vaccination can be an important aid in the reduction of these economic losses.

Copyright © 2011 Elsevier Ltd. All rights reserved.



Related Articles
Transplacental transmission of Bluetongue virus serotype 8 in ewes in early and mid gestation.
Vet Microbiol. 2011
Transplacental transmission of Bluetongue virus serotype 8 in ewes in early and mid gestation.
van der Sluijs M, Timmermans M, Moulin V, Noordegraaf CV, Vrijenhoek M, Debyser I, de Smit AJ, Moormann R. Vet Microbiol. 2011 Apr 21; 149(1-2):113-25. Epub 2010 Nov 9.
Vaccines against bluetongue in Europe.
Comp Immunol Microbiol Infect ...
Vaccines against bluetongue in Europe.
Savini G, MacLachlan NJ, Sanchez-Vizcaino JM, Zientara S. Comp Immunol Microbiol Infect Dis. 2008 Mar; 31(2-3):101-20. Epub 2007 Aug 31.
Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Vet Microbiol. 2009
Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G, Hamers C, Conte A, Migliaccio P, Bonfini B, Teodori L, Di Ventura M, Hudelet P, Schumacher C, Caporale V. Vet Microbiol. 2009 Jan 1; 133(1-2):1-8. Epub 2008 Jun 8.
Review Vaccines for bluetongue.
Aust Vet J. 1996
Review Vaccines for bluetongue.
Murray PK, Eaton BT. Aust Vet J. 1996 Jun; 73(6):207-10.
Review Bluetongue vaccines: the past, present and future.
Expert Rev Vaccines. 2009
Review Bluetongue vaccines: the past, present and future.
Bhanuprakash V, Indrani BK, Hosamani M, Balamurugan V, Singh RK. Expert Rev Vaccines. 2009 Feb; 8(2):191-204.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.